Category: Latest News
-
Sanofi Halts Phase 3 CIDP Trial for Riliprubart Following Interim Review (SAN)
Sanofi (NASDAQ:SNY) said on Wednesday that it has decided to discontinue the phase 3 MOBILIZE trial evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who have not responded to standard treatments. The decision follows an interim assessment conducted by an independent data monitoring committee, which concluded that the study was unlikely to achieve…
-
U.S.-Iran Tensions, Inflation Data and Oracle Earnings Dominate Market Focus: Dow Jones, S&P, Nasdaq, Wall Street Futures
U.S. equity futures traded lower on Wednesday as investors assessed renewed military action between the United States and Iran while awaiting a closely watched inflation report and quarterly results from software giant Oracle (NYSE:ORCL). Markets were also digesting the launch of Anthropic’s latest artificial intelligence model, a revised version of its previously restricted “Mythos-class” technology…
-
Stocks Close Mixed as Iran Headlines Upend Early Rally
Wall Street ended Tuesday on a split note, with the Dow Jones Industrial Average managing a narrow gain while technology stocks dragged the Nasdaq and S&P 500 lower. A promising morning that saw chip stocks bouncing from recent lows was derailed at midday when President Donald Trump said the United States “must respond” after Iran…
-
OpenAI Moves Toward IPO as Wave of Major AI Listings Builds Momentum
OpenAI has confidentially submitted paperwork for an initial public offering, paving the way for what could become one of the most closely watched stock market debuts in years and a potentially significant liquidity event for its early backers. The filing follows Anthropic’s recent announcement that it intends to pursue its own public listing and comes…
-
GMEX Robotics Secures $2 Million PIPE Financing at 20% Premium to Market Price (GMEX)
The AI robotics company raised fresh capital through a private placement priced above the recent market close, providing funding for operations, growth initiatives, and potential acquisitions. Key Investor Takeaways Why GMEX Stock Is in Focus GMEX Robotics announced that it has entered into a securities purchase agreement with investors for a private investment in public…
-
BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM)
The regenerative medicine company added experienced healthcare, biotech, and investment professionals to its board while highlighting governance and growth initiatives tied to its planned Nasdaq uplisting. Key Investor Takeaways Why BSEM Stock Is in Focus BioStem Technologies announced the appointment of Mark Glickman, Steven D. Sonenreich, and Rayna Lesser Hannaway to its Board of Directors,…
-
Kraig Biocraft Laboratories Sets Recombinant Spider Silk Production Record with Nearly 2.5 Metric Ton Harvest (KBLB)
The latest production cycle delivered the company’s largest-ever output, highlighting ongoing efforts to scale commercial recombinant spider silk manufacturing. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Biocraft Laboratories announced the completion of its largest production cycle on record, generating nearly 2.5 metric tons of recombinant spider silk cocoons from harvest activities conducted…
-
American Fusion Announces 5MW Texatron Fusion Engine Testing Roadmap and Validation Timeline (AMFN)
The fusion energy developer outlined a multi-phase testing plan, regulatory progress, and corporate milestones as it advances its pre-production Texatron™ Fusion Engine platform. Key Investor Takeaways Why AMFN Stock Is in Focus The key development is American Fusion’s release of a structured testing and validation schedule for its 5MW Pre-Production Texatron™ Fusion Engine. The company…
-
Wall Street Futures Signal Stronger Start to Tuesday Trading: Dow Jones, S&P, Nasdaq
U.S. stock futures pointed to a firmer open on Tuesday, suggesting markets could extend gains after finishing the previous session mostly higher, despite retreating significantly from their intraday peaks. Investor sentiment appeared to improve following a sharp decline in oil prices, with U.S. crude futures falling more than 2%. Oil prices dropped below $90 per…
-
J.M. Smucker Tops Quarterly Forecasts as Revenue and Earnings Beat Expectations (SJM)
The J.M. Smucker Co. (NYSE:SJM) reported fourth-quarter results that came in ahead of Wall Street expectations, sending its shares up 4.2% in premarket trading following the announcement. For the quarter ended April 30, the food products company posted adjusted earnings per share of $2.77, exceeding the analyst consensus estimate of $2.65 by $0.12. Revenue totaled…